Repros Therapeutics (RPRX) Tops Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $57.77 +3.57%
Financial Fact:
Loss per share - basic and diluted:: -0.17
Today's EPS Names:
CRMT, More
Financial Fact:
Loss per share - basic and diluted:: -0.17
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Repros Therapeutics (NASDAQ: RPRX) reported Q3 EPS of ($0.32), $0.07 better than the analyst estimate of ($0.39).
For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- FactSet Research Systems (FDS) PT Raised to $253 at Jefferies
- Isabella Bank added to Russell 2000 index after Nasdaq listing
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
